Actinium Pharmaceuticals
ATNM
#10526
Rank
NZ$67.01 M
Marketcap
NZ$2.13
Share price
2.52%
Change (1 day)
-21.46%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -NZ$43.47 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.09 Million. In 2025 the company made an earning of -NZ$63.33 Million, an increase over its 2024 earnings that were of -NZ$73.59 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$43.47 Million-31.36%
2025 -NZ$63.33 Million-13.95%
2024 -NZ$73.59 Million-18.87%
2023 -NZ$90.71 Million52.24%
2022 -NZ$59.58 Million36.61%
2021 -NZ$43.62 Million11.48%
2020 -NZ$39.13 Million1.46%
2019 -NZ$38.56 Million-7.37%
2018 -NZ$41.63 Million-11.46%
2017 -NZ$47.02 Million10.67%
2016 -NZ$42.49 Million15.7%
2015 -NZ$36.72 Million-14.86%
2014 -NZ$43.13 Million129.19%
2013 -NZ$18.82 Million-8.55%
2012 -NZ$20.58 Million
2010 NZ$0.01 M-152.15%
2009 -NZ$0.03 Million-39.8%
2008 -NZ$0.05 Million120.29%
2007 -NZ$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-NZ$64.98 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.33 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.67 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA